APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ubenimex Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ubenimex Capsules Market Outlook and Growth Opportunities 2026

Report ID 174044230427 December 2025193 pages

Choose your research edition.

Industry ResearchUbenimex Capsules Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Ubenimex Capsules Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Ubenimex Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ubenimex Capsules Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Ubenimex Capsules Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Ubenimex Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ubenimex Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ubenimex Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ubenimex Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ubenimex Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ubenimex Capsules market include Eiger Biopharmaceuticals, Nippon Kayaku, Chengdu Easton Biopharmaceuticals, Sichuan Green Leaf Pharmaceutical and Zhejiang Apeloa Kangyu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ubenimex Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ubenimex Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ubenimex Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ubenimex Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Ubenimex Capsules Segment by Company

Eiger Biopharmaceuticals

Nippon Kayaku

Chengdu Easton Biopharmaceuticals

Sichuan Green Leaf Pharmaceutical

Zhejiang Apeloa Kangyu Pharmaceutical

Ubenimex Capsules Segment by Type

10 mg

30 mg

Ubenimex Capsules Segment by Application

Hospital Pharmacy

Retail Pharmacy

Ubenimex Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ubenimex Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ubenimex Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ubenimex Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Ubenimex Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ubenimex Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ubenimex Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ubenimex Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ubenimex Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ubenimex Capsules industry.

Chapter 3: Detailed analysis of Ubenimex Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ubenimex Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ubenimex Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ubenimex Capsules Industry Trends Table 2. Ubenimex Capsules Industry Drivers Table 3. Ubenimex Capsules Industry Opportunities and Challenges Table 4. Ubenimex Capsules Industry Restraints Table 5. Global Ubenimex Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ubenimex Capsules Revenue Share by Company (2021-2026) Table 7. Global Ubenimex Capsules Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Ubenimex Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Ubenimex Capsules Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Ubenimex Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ubenimex Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Ubenimex Capsules Company, Product Type & Application Table 13. Global Ubenimex Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ubenimex Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10 mg Table 18. Significant Companies of 30 mg Table 19. Global Ubenimex Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Ubenimex Capsules Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Ubenimex Capsules Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Ubenimex Capsules Sales Volume Share by Type (2021-2026) Table 23. Global Ubenimex Capsules Sales Volume Share by Type (2027-2032) Table 24. Global Ubenimex Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ubenimex Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Ubenimex Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Ubenimex Capsules Sales Value Share by Type (2021-2026) Table 28. Global Ubenimex Capsules Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacy Table 30. Significant Companies of Retail Pharmacy Table 31. Global Ubenimex Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Ubenimex Capsules Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Ubenimex Capsules Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Ubenimex Capsules Sales Volume Share by Application (2021-2026) Table 35. Global Ubenimex Capsules Sales Volume Share by Application (2027-2032) Table 36. Global Ubenimex Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Ubenimex Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Ubenimex Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Ubenimex Capsules Sales Value Share by Application (2021-2026) Table 40. Global Ubenimex Capsules Sales Value Share by Application (2027-2032) Table 41. Global Ubenimex Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Ubenimex Capsules Sales by Region (2021-2026) & (K Units) Table 43. Global Ubenimex Capsules Sales Market Share by Region (2021-2026) Table 44. Global Ubenimex Capsules Sales by Region (2027-2032) & (K Units) Table 45. Global Ubenimex Capsules Sales Market Share by Region (2027-2032) Table 46. Global Ubenimex Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Ubenimex Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Ubenimex Capsules Sales Value Share by Region (2021-2026) Table 49. Global Ubenimex Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Ubenimex Capsules Sales Value Share by Region (2027-2032) Table 51. Global Ubenimex Capsules Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Ubenimex Capsules Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Ubenimex Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Ubenimex Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Ubenimex Capsules Sales by Country (2021-2026) & (K Units) Table 56. Global Ubenimex Capsules Sales Market Share by Country (2021-2026) Table 57. Global Ubenimex Capsules Sales by Country (2027-2032) & (K Units) Table 58. Global Ubenimex Capsules Sales Market Share by Country (2027-2032) Table 59. Global Ubenimex Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Ubenimex Capsules Sales Value Market Share by Country (2021-2026) Table 61. Global Ubenimex Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Ubenimex Capsules Sales Value Market Share by Country (2027-2032) Table 63. Eiger Biopharmaceuticals Company Information Table 64. Eiger Biopharmaceuticals Business Overview Table 65. Eiger Biopharmaceuticals Ubenimex Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Eiger Biopharmaceuticals Ubenimex Capsules Product Portfolio Table 67. Eiger Biopharmaceuticals Recent Development Table 68. Nippon Kayaku Company Information Table 69. Nippon Kayaku Business Overview Table 70. Nippon Kayaku Ubenimex Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Nippon Kayaku Ubenimex Capsules Product Portfolio Table 72. Nippon Kayaku Recent Development Table 73. Chengdu Easton Biopharmaceuticals Company Information Table 74. Chengdu Easton Biopharmaceuticals Business Overview Table 75. Chengdu Easton Biopharmaceuticals Ubenimex Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Chengdu Easton Biopharmaceuticals Ubenimex Capsules Product Portfolio Table 77. Chengdu Easton Biopharmaceuticals Recent Development Table 78. Sichuan Green Leaf Pharmaceutical Company Information Table 79. Sichuan Green Leaf Pharmaceutical Business Overview Table 80. Sichuan Green Leaf Pharmaceutical Ubenimex Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sichuan Green Leaf Pharmaceutical Ubenimex Capsules Product Portfolio Table 82. Sichuan Green Leaf Pharmaceutical Recent Development Table 83. Zhejiang Apeloa Kangyu Pharmaceutical Company Information Table 84. Zhejiang Apeloa Kangyu Pharmaceutical Business Overview Table 85. Zhejiang Apeloa Kangyu Pharmaceutical Ubenimex Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Zhejiang Apeloa Kangyu Pharmaceutical Ubenimex Capsules Product Portfolio Table 87. Zhejiang Apeloa Kangyu Pharmaceutical Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Ubenimex Capsules Distributors List Table 91. Ubenimex Capsules Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Ubenimex Capsules Product Image Figure 2. Global Ubenimex Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ubenimex Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ubenimex Capsules Sales (2021-2032) & (K Units) Figure 5. Global Ubenimex Capsules Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Ubenimex Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10 mg Image Figure 10. 30 mg Image Figure 11. Global Ubenimex Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Ubenimex Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Ubenimex Capsules Sales Volume Share by Type (2021-2032) Figure 14. Global Ubenimex Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ubenimex Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ubenimex Capsules Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacy Image Figure 18. Retail Pharmacy Image Figure 19. Global Ubenimex Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Ubenimex Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Ubenimex Capsules Sales Volume Share by Application (2021-2032) Figure 22. Global Ubenimex Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Ubenimex Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Ubenimex Capsules Sales Value Share by Application (2021-2032) Figure 25. Global Ubenimex Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Ubenimex Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Ubenimex Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Ubenimex Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Ubenimex Capsules Sales Value (2021-2032) & (US$ Million) Figure 30. North America Ubenimex Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Ubenimex Capsules Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Ubenimex Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Ubenimex Capsules Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Ubenimex Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Ubenimex Capsules Sales Value (2021-2032) & (US$ Million) Figure 36. South America Ubenimex Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Ubenimex Capsules Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Ubenimex Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Ubenimex Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Ubenimex Capsules Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Ubenimex Capsules Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 10 mg
  • 30 mg
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • Eiger Biopharmaceuticals
  • Nippon Kayaku
  • Chengdu Easton Biopharmaceuticals
  • Sichuan Green Leaf Pharmaceutical
  • Zhejiang Apeloa Kangyu Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ubenimex Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Ubenimex Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Ubenimex Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ubenimex Capsules Market Dynamics
  1. 2.1 Ubenimex Capsules Industry Trends
  2. 2.2 Ubenimex Capsules Industry Drivers
  3. 2.3 Ubenimex Capsules Industry Opportunities and Challenges
  4. 2.4 Ubenimex Capsules Industry Restraints
3 Ubenimex Capsules Market by Company
  1. 3.1 Global Ubenimex Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Ubenimex Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Ubenimex Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Ubenimex Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Ubenimex Capsules Company Ranking (2024-2026)
  6. 3.6 Global Ubenimex Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Ubenimex Capsules Company Product Type and Application
  8. 3.8 Global Ubenimex Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ubenimex Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ubenimex Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ubenimex Capsules Market by Type
  1. 4.1 Ubenimex Capsules Type Introduction
  2. 4.1.1 10 mg
  3. 4.1.2 30 mg
  4. 4.2 Global Ubenimex Capsules Sales Volume by Type
  5. 4.2.1 Global Ubenimex Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ubenimex Capsules Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Ubenimex Capsules Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Ubenimex Capsules Sales Value by Type
  9. 4.3.1 Global Ubenimex Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ubenimex Capsules Sales Value by Type (2021-2032)
  11. 4.3.3 Global Ubenimex Capsules Sales Value Share by Type (2021-2032)
5 Ubenimex Capsules Market by Application
  1. 5.1 Ubenimex Capsules Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Ubenimex Capsules Sales Volume by Application
  5. 5.2.1 Global Ubenimex Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Ubenimex Capsules Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Ubenimex Capsules Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Ubenimex Capsules Sales Value by Application
  9. 5.3.1 Global Ubenimex Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Ubenimex Capsules Sales Value by Application (2021-2032)
  11. 5.3.3 Global Ubenimex Capsules Sales Value Share by Application (2021-2032)
6 Ubenimex Capsules Regional Sales and Value Analysis
  1. 6.1 Global Ubenimex Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ubenimex Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Ubenimex Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Ubenimex Capsules Sales by Region (2027-2032)
  5. 6.3 Global Ubenimex Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ubenimex Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ubenimex Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ubenimex Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Ubenimex Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ubenimex Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Ubenimex Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ubenimex Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Ubenimex Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ubenimex Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ubenimex Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ubenimex Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Ubenimex Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ubenimex Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ubenimex Capsules Sales Value Share by Country, 2025 VS 2032
7 Ubenimex Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Ubenimex Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ubenimex Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ubenimex Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Ubenimex Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Ubenimex Capsules Sales by Country (2027-2032)
  6. 7.4 Global Ubenimex Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ubenimex Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ubenimex Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ubenimex Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ubenimex Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ubenimex Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eiger Biopharmaceuticals
  2. 8.1.1 Eiger Biopharmaceuticals Company Information
  3. 8.1.2 Eiger Biopharmaceuticals Business Overview
  4. 8.1.3 Eiger Biopharmaceuticals Ubenimex Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eiger Biopharmaceuticals Ubenimex Capsules Product Portfolio
  6. 8.1.5 Eiger Biopharmaceuticals Recent Developments
  7. 8.2 Nippon Kayaku
  8. 8.2.1 Nippon Kayaku Company Information
  9. 8.2.2 Nippon Kayaku Business Overview
  10. 8.2.3 Nippon Kayaku Ubenimex Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Nippon Kayaku Ubenimex Capsules Product Portfolio
  12. 8.2.5 Nippon Kayaku Recent Developments
  13. 8.3 Chengdu Easton Biopharmaceuticals
  14. 8.3.1 Chengdu Easton Biopharmaceuticals Company Information
  15. 8.3.2 Chengdu Easton Biopharmaceuticals Business Overview
  16. 8.3.3 Chengdu Easton Biopharmaceuticals Ubenimex Capsules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chengdu Easton Biopharmaceuticals Ubenimex Capsules Product Portfolio
  18. 8.3.5 Chengdu Easton Biopharmaceuticals Recent Developments
  19. 8.4 Sichuan Green Leaf Pharmaceutical
  20. 8.4.1 Sichuan Green Leaf Pharmaceutical Company Information
  21. 8.4.2 Sichuan Green Leaf Pharmaceutical Business Overview
  22. 8.4.3 Sichuan Green Leaf Pharmaceutical Ubenimex Capsules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sichuan Green Leaf Pharmaceutical Ubenimex Capsules Product Portfolio
  24. 8.4.5 Sichuan Green Leaf Pharmaceutical Recent Developments
  25. 8.5 Zhejiang Apeloa Kangyu Pharmaceutical
  26. 8.5.1 Zhejiang Apeloa Kangyu Pharmaceutical Company Information
  27. 8.5.2 Zhejiang Apeloa Kangyu Pharmaceutical Business Overview
  28. 8.5.3 Zhejiang Apeloa Kangyu Pharmaceutical Ubenimex Capsules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang Apeloa Kangyu Pharmaceutical Ubenimex Capsules Product Portfolio
  30. 8.5.5 Zhejiang Apeloa Kangyu Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ubenimex Capsules Value Chain Analysis
  2. 9.1.1 Ubenimex Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ubenimex Capsules Sales Mode & Process
  6. 9.2 Ubenimex Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ubenimex Capsules Distributors
  9. 9.2.3 Ubenimex Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst